The knockdown of DLC-1 increases GTP-bound RhoA and tumorigenic growth, and expression of constitutively active RhoA in these cells accelerate liver tumor formation, suggesting that DLC-1 acts as tumor suppressor [94]. This evidence concerns the gene DLC1 and neoplasm.